Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction.

Angiotensin II (ATII), a potent vasoconstrictor, causes hypertension, promotes infiltration of myelomonocytic cells into the vessel wall, and stimulates both vascular and inflammatory cell NADPH oxidases. The predominant source of reactive oxygen species, eg, vascular (endothelial, smooth muscle, adventitial) versus phagocytic NADPH oxidase, and the role of myelomonocytic cells in mediating arterial hypertension have not been defined yet.
Angiotensin II (1 mg · kg(-1) · d(-1) for 7 days) increased the number of both CD11b(+)Gr-1(low)F4/80(+) macrophages and CD11b(+)Gr-1(high)F4/80(-) neutrophils in mouse aorta (verified by flow cytometry). Selective ablation of lysozyme M-positive (LysM(+)) myelomonocytic cells by low-dose diphtheria toxin in mice with inducible expression of the diphtheria toxin receptor (LysM(iDTR) mice) reduced the number of monocytes in the circulation and limited ATII-induced infiltration of these cells into the vascular wall, whereas the number of neutrophils was not reduced. Depletion of LysM(+) cells attenuated ATII-induced blood pressure increase (measured by radiotelemetry) and vascular endothelial and smooth muscle dysfunction (assessed by aortic ring relaxation studies) and reduced vascular superoxide formation (measured by chemiluminescence, cytochrome c assay, and oxidative fluorescence microtopography) and the expression of NADPH oxidase subunits gp91(phox) and p67(phox) (assessed by Western blot and mRNA reverse-transcription polymerase chain reaction). Adoptive transfer of wild-type CD11b(+)Gr-1(+) monocytes into depleted LysM(iDTR) mice reestablished ATII-induced vascular dysfunction, oxidative stress, and arterial hypertension, whereas transfer of CD11b(+)Gr-1(+) neutrophils or monocytes from gp91(phox) or ATII receptor type 1 knockout mice did not. CONCLUSIONS- Infiltrating monocytes with a proinflammatory phenotype and macrophages rather than neutrophils appear to be essential for ATII-induced vascular dysfunction and arterial hypertension.
AuthorsPhilip Wenzel, Maike Knorr, Sabine Kossmann, Jan Stratmann, Michael Hausding, Swenja Schuhmacher, Susanne H Karbach, Melanie Schwenk, Nir Yogev, Eberhard Schulz, Matthias Oelze, Stephan Grabbe, Helmut Jonuleit, Christian Becker, Andreas Daiber, Ari Waisman, Thomas Münzel
JournalCirculation (Circulation) Vol. 124 Issue 12 Pg. 1370-81 (Sep 20 2011) ISSN: 1524-4539 [Electronic] United States
PMID21875910 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD11b
  • Gr-1 protein, mouse
  • Reactive Oxygen Species
  • Receptors, Chemokine
  • Vasoconstrictor Agents
  • Angiotensin II
  • Nitric Oxide
  • Muramidase
  • lysozyme M, mouse
  • Angiotensin II (pharmacology)
  • Animals
  • Antigens, CD11b (metabolism)
  • Endothelium, Vascular (immunology, metabolism)
  • Gene Expression (immunology)
  • Hypertension (chemically induced, immunology, metabolism)
  • Macrophages (immunology, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Monocytes (immunology, metabolism)
  • Muramidase (genetics, immunology, metabolism)
  • Muscle, Smooth, Vascular (immunology, metabolism)
  • Neutrophils (immunology, metabolism)
  • Nitric Oxide (metabolism)
  • Oxidative Stress (physiology)
  • Reactive Oxygen Species (metabolism)
  • Receptors, Chemokine (metabolism)
  • Respiratory Burst (physiology)
  • Vasculitis (chemically induced, immunology, metabolism)
  • Vasoconstrictor Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: